Swapping Chemo for Blincyto Helped More Kids With High-Risk Leukemia
Replacing two cycles of intensive chemotherapy with Blincyto raised four-year event-free survival to 83% from 70.3% in children with high-risk B-cell ALL, with far fewer infections. Read more: https://www.curetoday.com/view/swapping-chemo-for-blincyto-helped-more-kids-with-high-risk-leukemia
3 days ago

